@article{922638,
      recid = {922638},
      author = {Theobald, Matthias,},
      title = {Current immunotherapeutic strategies in cancer /},
      pages = {1 online resource.},
      abstract = {This book offers a comprehensive review of recent advances  in cancer immunotherapy, and explores the value and  limitations of the most effective current therapeutic  strategies and emerging treatment modalities. It discusses  in detail the successes achieved using monoclonal  antibodies (mAbs), including developments with regard to  conjugated mAbs and also bispecific mAbs as novel treatment  options for leukemia and solid tumors. It also examines the  advances toward personalized immunotherapy, focusing on the  effectiveness of adoptive cell therapy using genetically  engineered T cells with tumor-associated antigen-specific  T-cell receptors and chimeric antigen receptors, as well as  the role of tailored vaccines based on the patient's cancer  mutanome. Further, it describes the impressive therapeutic  results recently achieved with checkpoint inhibitors, and  analyzes novel strategies to modulate the immunosuppressive  tumor microenvironment. Written by leading international  experts and providing up-to-date information on emerging  strategies, such as oncolytic virus-based therapy,  epigenetic therapy, and combination therapy, the book  appeals to all those with an interest in immunotherapy as  it comes of age.},
      url = {http://library.usi.edu/record/922638},
      doi = {https://doi.org/10.1007/978-3-030-23765-3},
}